First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | -50.72% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -33.85% | ||||
| Operating Income | 33.85% | ||||
| Income Before Tax | 33.89% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 33.89% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 33.89% | ||||
| EBIT | 33.85% | ||||
| EBITDA | 33.89% | ||||
| EPS Basic | 34.10% | ||||
| Normalized Basic EPS | 34.10% | ||||
| EPS Diluted | 34.10% | ||||
| Normalized Diluted EPS | 34.10% | ||||
| Average Basic Shares Outstanding | 0.32% | ||||
| Average Diluted Shares Outstanding | 0.32% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||